Hungarian Hire for Growing Kantar Health

Kantar Health has announced the expansion of its Treatment Value Practice into Central and Eastern Europe (CEE) and appointed Dr. Pali Kolláth as Regional Director, CEE and Treatment Value Practice, based in Budapest, Hungary.

In his new role Kolláth, who has 18 years of pharmaceutical industry experience, will be responsible for directing strategic development for the Treatment Value Practice in CEE; building relationships with key decision-makers in the core countries of the region; and driving business development.

He was most recently Director, CEE Regional Pricing and Market Access at Merck; before this he worked at companies including Wyeth and Pfizer. A veterinary medical doctor with degrees from Hungary and the USA, he holds a Master of Business Administration degree from Edinburgh Business School in the UK.

Werner Guminski, CEO, Global Practice and Region Europe, for Kantar Health, says the CEE region 'represents a significant and growing portion of the global pharmaceutical market', and adds: 'Pali's presence in CEE will allow us to help our clients optimize market access and business performance in this fast-growing region.'

Kantar Health, online at www.kantarhealth.com , was formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment. It has more than forty offices throughout the Americas, Europe, Asia-Pacific, the Middle East and Africa.

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Kantar Health
• All news